Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
CAH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$93.17 - $150.12
Previous CloseN/A
Volume818.36K
Average Volume (3M)2.78M
Market Cap
$35.69B
Enterprise Value$32.61B
Total Cash (Recent Filing)$3.33B
Total Debt (Recent Filing)$7.68B
Price to Earnings (P/E)27.9
Beta0.46
Next Earnings
Aug 07, 2025EPS Estimate
1.98Last Dividend Ex-Date
Apr 01, 2025Dividend Yield1.39%
Share Statistics
EPS (TTM)5.36
Shares Outstanding241,568,000
10 Day Avg. Volume2,384,023
30 Day Avg. Volume2,777,704
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.40
Enterprise Value/Ebitda11.59
Forecast
1Y Price Target
$154.22Price Target Upside3.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Earnings GrowthThe new management's impressive earnings track record suggests a strong foundation for continued growth.
Market PositionThe company's limited exposure to significant healthcare funding threats is seen as an advantage.
Strategic AcquisitionsThe strategic acquisition of ADS is expected to provide immediate earnings benefits, which are not yet reflected in the current guidance.
Bears Say
Financial PerformanceGMPD AOI could come in roughly $90-$100M lower, creating potentially a 300-350bps drag to FY26 adj. EPS growth.
GMPD Segment ChallengesThere is significant uncertainty surrounding GMPD’s profitability and many unknowns around the impact of tariffs on this business.
Tariff ImpactRecent stock volatility is largely influenced by tariff headlines, which significantly impact the GMPD segment.
---
Ownership Overview
0.26% Insiders
20.74% Mutual Funds
0.81% Other Institutional Investors
50.49% Public Companies and
Individual Investors
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $93.17 and its highest was $150.12 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $35.69B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 07, 2025 which is in 95 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on May 01, 2025. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.174 by $0.176.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Thriceyearly dividend of $0.505 which represents an annual dividend yield of 1.39%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 1.98.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 241,568,000 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $2.35 in its last earnings report, beating expectations of $2.174. Following the earnings report the stock price went up 3.001%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
---
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$154.22 (3.14% Upside)
$154.22 (3.14% Upside)
Blogger Sentiment
Neutral
CAH Sentiment 57%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $432.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.98%
12-Months-Change
Fundamentals
Return on Equity
-43.80%
Trailing 12-Months
Asset Growth
0.92%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
---
CAH Company Deck
---
CAH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, strategic customer onboarding, and successful acquisitions, contributing to positive growth. However, challenges in the GMPD segment due to tariff impacts posed significant concerns, which the company is actively working to mitigate.Read More>---
CAH Revenue Breakdown
92.59% Pharmaceutical and Specialty Solutions
5.46% Global Medical Products and Distribution
1.99% Other
---
CAH Stock 12 Month Forecast
Average Price Target
$154.22
▲(3.14% Upside)
Technical Analysis
---